Armstrong Advisory Group’s Quest Diagnostics DGX Stock Holding History

Armstrong Advisory Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4K	Hold	54	–	–	﹤0.01%	686
2026 Q1	$10.6K	Hold	54	–	–	﹤0.01%	679
2025 Q4	$9.37K	Hold	54	–	–	﹤0.01%	684
2025 Q3	$10.3K	Hold	54	–	–	﹤0.01%	673
2025 Q2	$9.7K	Hold	54	–	–	﹤0.01%	672
2025 Q1	$8.15K	Hold	54	–	–	﹤0.01%	651
2024 Q4	$8.15K	Hold	54	–	–	﹤0.01%	651
2024 Q3	$8.38K	Hold	54	–	–	﹤0.01%	613
2024 Q2	$7.39K	Hold	54	–	–	﹤0.01%	618
2024 Q1	$7.45K	Hold	54	–	–	﹤0.01%	606
2023 Q4	$7.45K	Sell	54 -22	-29%	-$2.89K	﹤0.01%	606
2023 Q3	$9.26K	Buy	76 +22	+41%	+$2.93K	﹤0.01%	611
2023 Q2	$7.59K	Hold	54	–	–	﹤0.01%	621
2023 Q1	$7.64K	Hold	54	–	–	﹤0.01%	605
2022 Q4	$8.45K	Buy	+54	New	+$7.76K	﹤0.01%	610

Other funds holding DGX

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

JWM

JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Armstrong Advisory Group's DGX Position: Q2 2026 in Review

Armstrong Advisory Group held its Quest Diagnostics (DGX) position steady in Q2 2026 at 54 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

Armstrong Advisory Group first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Armstrong Advisory Group held 54 shares of Quest Diagnostics worth $11.4K as of Q2 2026.
Armstrong Advisory Group left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #686 holding.
Armstrong Advisory Group first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.